Using CRISPR/Cas9‐edited SULF1‐knockout primary HNSCC CAFs, we demonstrate that loss of SULF1 reduces fibroblast proliferation and markedly impairs cancer cell migration and invasion in vitro. This evidence concerns the gene SULF1 and cancer.